Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Outpatient Stem Cell Mobilization with Low and Intermediate Dose Cyclophosphamide Is a Safe and Effective Procedure in Newly Diagnosed Multiple Myeloma Patients Eligible for Stem Cell Transplantation

Alessandra Pompa, Laura Paris, MD, Francesca Guidotti, MD, Valeria Ferla, MD, Monica Galli, MD PhD, Alessandro Rambaldi, MD Prof, Luca Baldini, Agostino Cortelezzi, Prof

Blood (2017) 130 (Supplement 1): 4476.

https://doi.org/10.1182/blood.V130.Suppl_1.4476.4476

Published: 2017

Journal Articles

Outpatient Stem Cell Mobilization with Intermediate-Dose Cyclophosphamide Is a Safe and Effective Procedure

Alessandra Pompa, MD, Anna Ines Gregorini, MD, Francesca Guidotti, MD, Maria Cecilia Goldaniga, MD, Francesca Gaia Rossi, MD, Riccardo Marcolin, Luca Baldini, MD Prof, Agostino Cortelezzi, MD

Blood (2016) 128 (22): 5734.

https://doi.org/10.1182/blood.V128.22.5734.5734

Published: 2016

Journal Articles

Four Cases of Lenalidomide-Associated Immune Thrombocytopenia

Alessandra Pompa, MD, Francesca Guidotti, MD, Anna Ines Gregorini, MD, Maria Cecilia Goldaniga, MD, Francesca Gaia Rossi, MD, Luca Baldini, MD Prof, Agostino Cortelezzi, MD

Blood (2016) 128 (22): 4927.

https://doi.org/10.1182/blood.V128.22.4927.4927

Published: 2016

Journal Articles

Peripherally Inserted Central Catheters (PICCs) Implantation in the Clinical Management of Oncohematologic Patients: Results of a Large Multicenter, Retrospective Study of the REL Group (Rete Ematologica Lombarda - Lombardy Hematologic Network, Italy)

Nicola Stefano Fracchiolla, MD, Elisabetta Todisco, MD PhD, Andrea Bilancia, Sara Gandolfi, MD, Valentina Mancini, MD, Laura Marbello, MD, Massimo Bernardi, MD, Andrea Assanelli, MD, Nicola Orofino, MD, Ramona Cassin, MD, Mariarita Sciumè, MD, Francesca Guidotti, MD, Roberto Cairoli, MD, Fabio Ciceri, MD, Armando Santoro, MD, Agostino Cortelezzi, MD, Giuseppe Rossi, MD

Blood (2015) 126 (23): 5611.

https://doi.org/10.1182/blood.V126.23.5611.5611

Published: 2015

Journal Articles

Secondary Acute Myeloid Leukemia Is an Heterogeneous Subgroup of Elderly AML Where Patient’s Fitness Criteria and ELN Prognostic Stratification Can be Applied to Guide Treatment Decisions: An Analysis of 127 Patients By the Network Rete Ematologica Lombarda (REL)

Erika Borlenghi, MD, Chiara Pagani, MD, Claudia Basilico, MD, Massimo Bernardi, MD, Matteo Carrabba, MD, Nicola Fracchiolla, MD, Francesca Guidotti, MD, Laura Marbello, MD, Andrea Ferrario, MD, Silvia Ferrari, MD, Francesca Schieppati, MD, Daniela Dalceggio, MD, Giuseppe Rossi, MD

Blood (2014) 124 (21): 953.

https://doi.org/10.1182/blood.V124.21.953.953

Published: 2014

Journal Articles

Validating the Patient's "Fitness" Criteria Proposed to Guide Treatment Decision in Elderly AML: a Multicenter Study on a Population-Based Series of 362 Patients By the Network "Rete Ematologica Lombarda" (REL)

Erika Borlenghi, MD, Chiara Pagani, MD, Claudia Basilico, MD, Massimo Bernardi, MD, Nicola Fracchiolla, MD, Francesca Guidotti, MD, Laura Marbello, MD, Andrea Ferrario, MD, Carlo Messina, MD, Emanuele Ravano, MD, Cinzia Lamorgese, Marta Petullà, Giuseppe Rossi, MD

Blood (2014) 124 (21): 279.

https://doi.org/10.1182/blood.V124.21.279.279

Published: 2014

Journal Articles

Chronic Idiopathic Neutropenia In Adults: Clinical Features In a 4-Year Prospective Study

Bruno Fattizzo, MD, Tommaso Radice, MD, Francesca Guidotti, MD, Anna Zaninoni, BS, Alberto Ciani, MD, Dario Consonni, MD, Agostino Cortelezzi, MD, Wilma Barcellini, MD

Blood (2013) 122 (21): 1026.

https://doi.org/10.1182/blood.V122.21.1026.1026

Published: 2013

Journal Articles

Immune Thrombocytopenia Associated to Low-Dose Alemtuzumab Therapy in Chronic Lymphocytic Leukemia: A Single Retrospective Center Experience

Gianluigi Reda, MD, Francesco Maura, MD, Giuseppe Gritti, MD, Daniele Vincenti, MD, Mariarita Sciumé, MD, Nicola Orofino, MD, Anna Ines Gregorini, MD, Cristina Bucelli, MD, Francesca Binda, MD, Francesca Guidotti, MD, Alfonso Piciocchi, Francesco Rodeghiero, MD, Antonino Neri, Agostino Cortelezzi, MD

Blood (2012) 120 (21): 4598.

https://doi.org/10.1182/blood.V120.21.4598.4598

Published: 2012

Journal Articles

5-Azacitidine Therapy in Patients with Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia and Acute Myeloid Leukemia: a Single Institution Experience

Alessandra Freyrie, MD, Gianluigi Reda, MD, Daniele Vincenti, MD, Mariarita Sciumé, MD, Francesca Binda, MD, Francesca Guidotti, MD, Agostino Cortelezzi, MD

Blood (2012) 120 (21): 4963.

https://doi.org/10.1182/blood.V120.21.4963.4963

Published: 2012

NARROW

Outpatient Stem Cell Mobilization with Low and Intermediate Dose Cyclophosphamide Is a Safe and Effective Procedure in Newly Diagnosed Multiple Myeloma Patients Eligible for Stem Cell Transplantation

Outpatient Stem Cell Mobilization with Intermediate-Dose Cyclophosphamide Is a Safe and Effective Procedure

Four Cases of Lenalidomide-Associated Immune Thrombocytopenia

Peripherally Inserted Central Catheters (PICCs) Implantation in the Clinical Management of Oncohematologic Patients: Results of a Large Multicenter, Retrospective Study of the REL Group (Rete Ematologica Lombarda - Lombardy Hematologic Network, Italy)

Secondary Acute Myeloid Leukemia Is an Heterogeneous Subgroup of Elderly AML Where Patient’s Fitness Criteria and ELN Prognostic Stratification Can be Applied to Guide Treatment Decisions: An Analysis of 127 Patients By the Network Rete Ematologica Lombarda (REL)

Validating the Patient's "Fitness" Criteria Proposed to Guide Treatment Decision in Elderly AML: a Multicenter Study on a Population-Based Series of 362 Patients By the Network "Rete Ematologica Lombarda" (REL)

Chronic Idiopathic Neutropenia In Adults: Clinical Features In a 4-Year Prospective Study

Immune Thrombocytopenia Associated to Low-Dose Alemtuzumab Therapy in Chronic Lymphocytic Leukemia: A Single Retrospective Center Experience

5-Azacitidine Therapy in Patients with Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia and Acute Myeloid Leukemia: a Single Institution Experience

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only